| 08:17a | RBC Raises Price Target on Vertex Pharmaceuticals to $323 From $315, Maintains Sector P.. | MT |
| 06/07 | Pfizer, Moderna, BioNTech Sued for Alleged Patent Infringement Over COVID-19 Vaccine | MT |
| 06/07 | Transcript : Regeneron Pharmaceuticals, Inc. Presents at Jefferies 2023 Globa.. | CI |
| 06/06 | Moderna, Pfizer hit with new patent lawsuits over COVID vaccines | RE |
| 06/06 | BIONTECH : UBS reiterates its Neutral rating | MD |
| 06/06 | WuXi AppTec Co., Ltd. Announces Executive Changes | CI |
| 06/05 | Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data | RE |
| 06/05 | BIONTECH : Goldman Sachs sticks Neutral | MD |
| 06/02 | Insider Sell: Regeneron Pharmaceuticals | MT |
| 06/02 | European Equities Traded as American Depositary Receipts Move Higher in Friday US Tradi.. | MT |
| 06/02 | Sector Update: Health Care Stocks Advance Pre-Bell Friday | MT |
| 06/02 | BionTech SE and Oncoc4 Inc. Present Positive Phase 1/2 Data for Antibody Candidate Bnt3.. | CI |
| 06/02 | BioNTech, OncoC4 Say Preliminary Trial Data Show Anti-Tumor Activity in Investigational.. | MT |
| 06/02 | BioNTech, OncoC4's Drug Shows Anti-tumor Activity in Non-small Cell Lung Cancer Patient.. | MT |
| 06/01 | HC Wainwright Cuts Price Target on BioNTech to $181 From $198, Maintains Buy Rating | MT |
| 05/31 | Wuxi Apptec Co., Ltd. Approves Final Dividend for the Financial Year End 31 December 20.. | CI |
| 05/31 | WuXi AppTec Co., Ltd. Approves Board Changes | CI |
| 05/30 | Transcript : Regeneron Pharmaceuticals, Inc. Presents at 4th Annual Oncology .. | CI |
| 05/26 | FTSE 100 Closes Friday Up 0.7% on Commodities Rebound, Signs of Debt Deal Progress | DJ |
| 05/26 | European Equities Snap 4-Day Losing Streak With Friday Rally | MT |
| 05/26 | UK Retail Sales Proved Bright Spot Amid Inflation Pain | DJ |
| 05/26 | Pfizer, BioNTech, EU Agree to Amend COVID-19 Vaccine Deal | MT |
| 05/26 | Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the Europe.. | CI |
| 05/26 | Pfizer, BioNTech Amend EU Vaccines Supply Contract amid Improved COVID-19 Situation | MT |
| 05/26 | Regeneron Says Linvoseltamab Shows 71% Objective Response Rate in Multiple Myeloma Phas.. | MT |
| 05/25 | Regeneron Pharmaceuticals, Inc. Provides Updated Data from Two Phase 2 Expansion Dose C.. | CI |
| 05/25 | FDA Grants Full Approval to Pfizer's Paxlovid for High-Risk Adults -- Update | DJ |
| 05/23 | Pharma Stocks Lead European Equities Modestly Lower in Tuesday Trading | MT |
| 05/23 | HC Wainwright Adjusts BioNTech's Price Target to $198 From $210, Keeps Buy Rating | MT |
| 05/22 | European Equities Close Mostly Lower Monday; Irish Regulator Fines Meta $1.3 Billion | MT |
| 05/22 | Global markets live: Ryanair, Micron, Nvidia, Albemarle, Exxon... | |
| 05/22 | HC Wainwright Adjusts Price Target on Genmab to $51 From $47, Keeps Buy Rating | MT |
| 05/22 | Sanofi, Regeneron's Lung Disease Drug Showed Sustained Benefit in Late-Stage Study | MT |
| 05/22 | Sanofi: smoker's lung drug benefit was swift and sustained in trial | RE |
| 05/19 | Genmab, AbbVie Say US FDA Approves Epkinly for Treating Diffuse Large B-cell Lymphoma | MT |
| 05/19 | U.S. FDA approves Genmab-AbbVie's blood cancer therapy | RE |
| 05/19 | Genmab Secures US FDA Approval for Epkinly for Relapsed/Refractory Diffuse Large B-Cell.. | MT |
| 05/19 | US FDA approves Genmab-AbbVie's blood cancer therapy | RE |
| 05/19 | U.S. Food and Drug Administration Approves Genmab A/S’s EPKINLY (epcoritamab-bysp).. | CI |
| 05/19 | Sector Update: Health Care Stocks Gain Premarket Friday | MT |
| 05/19 | CureVac Says Motion Granted to Transfer Pfizer/BioNTech Patent Litigation to Virginia | MT |
| 05/19 | CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology | RE |
| 05/19 | Curevac Wins Motion to Transfer Pfizer-BioNTech Vaccine Patent Case to Virginia | MT |
| 05/18 | BIONTECH : Berenberg reiterates its Buy rating | MD |
| 05/18 | Sector Update: Health Care Stocks Weaker Late Thursday | MT |
| 05/18 | Sector Update: Health Care Stocks Dropping Thursday Afternoon | MT |
| 05/18 | Sector Update: Health Care | MT |
| 05/18 | Sanofi, Regeneron Applaud US Supreme Court Ruling Against Amgen's Bid to Revive Repatha.. | MT |
| 05/18 | Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen -- Update | DJ |
| 05/18 | Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen | DJ |
| 05/18 | Deutsche Bank Cuts BioNTech's Price Target to $120 From $135, Maintains Hold Rating | MT |
| 05/18 | WHO recommends new COVID shots should target only XBB variants | RE |
| 05/18 | Amgen Bid to Revive Repatha Drug Patents Rejected by US Supreme Court | MT |
| 05/18 | U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents | RE |
| 05/18 | BIONTECH : Deutsche Bank sticks Neutral | MD |
| 05/17 | WuXi AppTech Co-Founder Dies | MT |
| 05/17 | Pharma Stocks Weigh Down European Equities in Wednesday Trading | MT |
| 05/17 | Redburn Upgrades BioNTech to Buy From Neutral, Adjusts Price Target to $170 From $165 | MT |
| 05/16 | Wuxi AppTec Co., Ltd Announces Demise of Ning Zhao, Executive Director and Senior Vice .. | CI |
| 05/16 | Transcript : Regeneron Pharmaceuticals, Inc. Presents at RBC Capital Markets .. | CI |
| 05/16 | HC Wainwright Adjusts Price Target on Genmab to $47 From $46, Maintains Buy Rating | MT |
| 05/16 | WEEKLY PREVIEW: Dates until May 29, 2023 | DP |
| 05/15 | Latest acquisition drives Dermapharm - share price rises sharply | DP |
| 05/15 | Latest acquisition drives drugmaker Dermapharm forward | DP |
| 05/12 | WEEKLY FORECAST: Dates until May 26, 2023 | DP |
| 05/12 | European Equities Trading in the US as American Depositary Receipts Appear Set to Close.. | MT |
| 05/12 | Decibel Therapeutics Says Spanish Regulators Approved Its Application for Clinical Tria.. | MT |
| 05/11 | Pfizer CEO calls US drug price plan 'negotiation with a gun to your head' | RE |
| 05/11 | Genmab : Mixed Q1; attractiveness remains intact, despite profitability miss | |
| 05/10 | Transcript : Genmab A/S, Q1 2023 Earnings Call, May 10, 2023 | CI |
| 05/10 | Tranche Update on Genmab A/S's Equity Buyback Plan announced on March 1, 2021. | CI |
| 05/10 | Genmab A/S Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 05/10 | Genmab A/S Provides Earnings Guidance for 2023 | CI |
| 05/10 | Genmab Q1 Net Profit Falls; Revenue Up
| MT |
| 05/10 | European Equities Traded as American Depositary Receipts Lower Again in Wednesday US Tr.. | MT |
| 05/10 | BIONTECH : Morgan Stanley reiterates its Neutral rating | MD |
| 05/09 | Insider Sell: Vertex Pharmaceuticals Inc | MT |
| 05/09 | Transcript : Regeneron Pharmaceuticals, Inc. Presents at Bank of America Secu.. | CI |
| 05/09 | Insider Sell: Vertex Pharmaceuticals Inc | MT |
| 05/09 | Transcript : Vertex Pharmaceuticals Incorporated Presents at Bank of America .. | CI |
| 05/09 | Pharma Stocks Weigh Down European Equities in Tuesday Trading | MT |
| 05/09 | UK Regulator Clears Moderna's COVID-19 Vaccine for Children Below Five Years Old | MT |
| 05/09 | Morgan Stanley Adjusts Price Target on BioNTech to $124 From $150, Maintains Equal-Weig.. | MT |
| 05/09 | BIONTECH : Berenberg reaffirms its Buy rating | MD |
| 05/09 | Berenberg Bank Adjusts BioNTech Price Target to $200 From $260, Maintains Buy Rating | MT |
| 05/09 | BIONTECH : Goldman Sachs reiterates its Neutral rating | MD |
| 05/09 | Evonik's pricing helps it beat profit estimates in tough first quarter | RE |
| 05/08 | BIONTECH : Jefferies reaffirms its Neutral rating | MD |
| 05/08 | Guggenheim Adjusts Price Target on Regeneron Pharmaceuticals to $935 From $960, Maintai.. | MT |
| 05/08 | BioNTech Affirms COVID-19 Vaccine Sale Target After First-Quarter Results Top Views | MT |
| 05/08 | Transcript : BioNTech SE, Q1 2023 Earnings Call, May 08, 2023 | CI |
| 05/08 | BioNTech 1Q Earnings, Revenue Drop on Waning Covid-19 Shot Sales | DJ |
| 05/08 | BioNTech Reiterates FY23 Outlook for COVID-19 Vaccine Revenue | MT |
| 05/08 | Cash-rich BioNTech broadens scope as COVID shot sales slide | RE |
| 05/08 | BioNTech's Q1 Earnings, Revenue Drop | MT |
| 05/08 | BioNTech SE Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 05/08 | BioNTech SE Provides Revenue Guidance for the Full Year 2023 | CI |
| 05/08 | BioNTech earnings drops on lower COVID vaccine sales | RE |
| 05/05 | European Equities Move Sharply Higher Friday, But End Week Lower | MT |
| 05/05 | RBC Cuts Price Target on Regeneron Pharmaceuticals to $811 From $830, Maintains Sector .. | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
